Skip to main content
Log in

All-Trans-Retinoic-Acid Unmasking Hypercalcemia of Hyperparathyroidism

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

We present a patient of acute promyelocytic leukaemia managed with all-trans-retinoic-acid and arsenic trioxide who developed hypercalcemia with target organ damage. The patient also was simultaneously discovered to be symptomatic from hyperparathyroidism, which was unmasked after ATRA administration. Patient was successfully managed without any interruption of ATRA therapy and parathyroidectomy. We discuss the mechanisms of ATRA in causing hypercalcemia and its possible role in index case in unmasking hyperparathyroidism. Present case refutes Occam’s razor and emphasise that known adverse effects shouldn’t withhold clinicians from working up for other common causes for a given condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L et al (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567–572

    CAS  PubMed  Google Scholar 

  2. Suzumiya J, Asahara F, Katakami H, Kimuran N, Hisano S, Okumura M et al (1994) Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report. Eur J Haematol 53(2):126–127

    Article  CAS  PubMed  Google Scholar 

  3. Sakakibara M, Ichikawa M, Amano Y, Matsuzawa S, Agematsu K, Mori T et al (1993) Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leuk Res 17(5):441–443

    Article  CAS  PubMed  Google Scholar 

  4. Sakamoto O, Yoshinari M, Rikiishi T, Fujiwara I, Imaizumi M, Tsuchiya S et al (2001) Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate. Pediatr Int 43(6):688–690

    Article  CAS  PubMed  Google Scholar 

  5. Niesvizky R, Siegel DS, Busquets X, Nichols G, Muindi J, Warrell RP Jr et al (1995) Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma. Br J Haematol 89(1):217–218

    Article  CAS  PubMed  Google Scholar 

  6. Chertow BS, Williams GA, Norris RM, Baker GR, Hargis GK (1977) Vitamin A stimulation of parathyroid hormone: interactions with calcium, hydrocortisone, and vitamin E in bovine parathyroid tissues and effects of vitamin A in man. Eur J Clin Invest 7(4):307–314

    Article  CAS  PubMed  Google Scholar 

  7. Nagasawa M, Okawa H (1994) All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP. Int J Hematol 59(2):143–144

    CAS  PubMed  Google Scholar 

  8. Cordoba R, Ramirez E, Lei SH, Lopez de la Guia A, Sanjurjo MJ, Carcas AJ et al (2008) Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid. Eur J Clin Pharmacol 64(10):1031–1032

    Article  CAS  PubMed  Google Scholar 

  9. Bennett MT, Sirrs S, Yeung JK, Smith CA (2005) Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole. Leuk Lymphoma 46(12):1829–1831

    Article  CAS  PubMed  Google Scholar 

  10. Lemez P (1995) Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day. Eur J Haematol 55(4):275–276

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was not funded by any institution or authority.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pankaj Malhotra.

Ethics declarations

Conflict of interest

None of the authors have any conflict of interest to mention.

Ethical approval

This article does not contain any studies with animals performed by any of the authors. This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from the participant included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanamandra, U., Sahu, K.K., Khadwal, A. et al. All-Trans-Retinoic-Acid Unmasking Hypercalcemia of Hyperparathyroidism. Indian J Hematol Blood Transfus 32 (Suppl 1), 41–45 (2016). https://doi.org/10.1007/s12288-015-0587-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0587-1

Keywords

Navigation